Hepatotoxicity is the risk factor with gemtuzumab ozogamicin treatment in acute myelogenous leukaemia patients

Publication date: Available online 21 May 2020Source: Clinics and Research in Hepatology and GastroenterologyAuthor(s): Sayed Aliul Hasan Abdi, Shatrunajay Shukla, Jasim Khan, Abdulaziz Al Zahrani
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research